Guido Würth

Join your colleagues for a deep-dive discussion in smaller groups to map out the next generation of TRP targets. You will brainstorm high-potential clinical candidates and cross-pollinate ideas from the ADC space to sharpen selection strategy before sharing your table’s thoughts and discussion back to the group.

• Identifying optimal tumor targets by evaluating density, internalization, and off-target risk
• Exploring current targets under development and their potential clinical impact
• Applying lessons from antibody-drug conjugates and other targeted therapies to guide RLT target selection

Thinking about entering radiopharma – or wish you’d known more before you did? Join seasoned leaders from R&D, CMC, clinical, and commercial as they share hard-won lessons, practical pitfalls, and insider insights across the entire development journey, and bring your questions to those who’ve navigated it firsthand.

• R&D and Preclinical: novel target choices, targeting molecules, linkers, chelators, preclinical dosimetry and more
• CMC and Regulatory: isotope properties, differences in supply chain, logistics networks, CMC innovations, regulatory considerations and more
• Clinical Development: clinical trial design, working with sites, working with clinical stakeholders, patient centric approaches and more